MEDERMA Trademark

Trademark Overview


On Monday, November 4, 2024, a trademark application was filed for MEDERMA with the United States Patent and Trademark Office. The USPTO has given the MEDERMA trademark a serial number of 98835009. The federal status of this trademark filing is EXAMINER'S AMENDMENT/PRIORITY ACTION MAILED as of Monday, December 9, 2024. This trademark is owned by Laboratoire HRA Pharma SAS. The MEDERMA trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical products and preparations for prevention and treatment of skin irritations, skin inflammations, skin lesions, blisters, corn, callus and acne; Patches containing medicated gel for medical use for skin care; Patches containing medicated gel for medical use for blisters; balms for medical use for skin care; Medical dressings; wound dressings in the form of foils and gel dressings; burn dressings; medical plasters for injury prevention and care; medical plasters for skin care; bunion pads; topical dermatological preparations that treat insect bites and stings; pharmaceutical preparations for the relief of insect bites; creams for dermatological use; gels for dermatological use; medicated ointments for treating dermatological conditions

Silicone scar sheets
mederma

General Information


Serial Number98835009
Word MarkMEDERMA
Filing DateMonday, November 4, 2024
Status656 - EXAMINER'S AMENDMENT/PRIORITY ACTION MAILED
Status DateMonday, December 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical products and preparations for prevention and treatment of skin irritations, skin inflammations, skin lesions, blisters, corn, callus and acne; Patches containing medicated gel for medical use for skin care; Patches containing medicated gel for medical use for blisters; balms for medical use for skin care; Medical dressings; wound dressings in the form of foils and gel dressings; burn dressings; medical plasters for injury prevention and care; medical plasters for skin care; bunion pads; topical dermatological preparations that treat insect bites and stings; pharmaceutical preparations for the relief of insect bites; creams for dermatological use; gels for dermatological use; medicated ointments for treating dermatological conditions
Goods and ServicesSilicone scar sheets

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 9, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code7 - Inactive - Insufficient fee received
Class Status DateMonday, December 9, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLaboratoire HRA Pharma SAS
Party Type10 - Original Applicant
Legal Entity Type34 - NOT AVAILABLE
AddressChâtillon 92320
FR

Trademark Events


Event DateEvent Description
Tuesday, December 3, 2024ASSIGNED TO EXAMINER
Monday, December 9, 2024COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Monday, December 9, 2024NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Monday, November 4, 2024NEW APPLICATION ENTERED
Monday, November 4, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 9, 2024EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Monday, December 9, 2024EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED